Microbiologic Testing for 503A Sterile-Compounding Pharmacies.

Area of Science:

• Pharmaceutical Science
• Microbiology
• Quality Control

Background:

• Sterile preparations require stringent control to prevent microbiologic contamination.
• Compounding pharmacists must adhere to controlled cleanroom conditions and environmental monitoring.
• United States Pharmacopeia (USP) Chapter <797> provides guidelines for sterile compounding.

Purpose of the Study:

• To discuss basic microbiology concepts relevant to sterile compounding.
• To outline microbial tests that can be performed in-house versus outsourced.
• To guide pharmacists in monitoring and interpreting cleanroom environments for 503A sterile compounding.

Main Methods:

• Review of current USP Chapter <797> guidelines.
• Discussion of essential cleanroom conditions and environmental monitoring techniques.
• Analysis of in-house versus outsourced microbial testing, including laboratory requirements.

Main Results:

• Identified key microbial tests for in-house interpretation and those requiring contract laboratories.
• Presented requirements for establishing an in-house microbiology laboratory.
• Examined the advantages and disadvantages of both in-house and outsourced testing strategies.

Conclusions:

• Pharmacists must understand microbiology and testing to ensure sterile preparation safety.
• Effective environmental monitoring and microbial testing are essential for contamination control.
• Strategic decisions regarding in-house or outsourced testing can optimize quality and compliance.